Patent ID: 9439953
Filing Date: 2016-09-13
CPC Classification: A23L,A23V,A61K,C12N,C12Y

Claim Text:
1. A method of preventing or treating a disorder or disease selected from the group consisting of: an inflammatory process of the intestine and its associated structures; an apoptosic process of the intestine and its associated structures; and an inflammatory intestinal disorder or disease; said method comprising: (a) providing a dietetic, a nutrient or a pharmaceutical composition formulated for oral, enteral or parenteral administration comprising: and the alkaline sphingomyelinase hydrolyzes a sphingomyelin to a ceramide and a phosphorylcholine, and the hydrolysis is optimal at about pH 9, (b) administering a therapeutically effective amount of the dietetic, nutrient or pharmaceutical composition to a subject in need thereof, thereby preventing or treating the inflammatory intestinal disease or disorder, the inflammatory process of the intestine and its associated structures; or the apoptosic process of the intestine and its associated structures.